ACTIVE

TriFinance Belgium

Financial year 2025 · Closed on 31/12/2025

Net result52,8 k €+102,8 %over 1 year
Revenue60,1 M €-11,4 %over 1 year
Equity1,7 M €+3,2 %over 1 year
Workforce428,7 ETP-8,5 %over 1 year

Identity

Source · BCE/KBO

TriFinance Belgium is a Public limited company incorporated in 2006. Its main activity is: Management consultancy activities. Its registered office is in Antwerpen. It employs on average 428,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0882.734.939
Incorporation
27/07/2006
Legal form
Public limited company
Registered office
Uitbreidingstraat 80
2600 Antwerpen · FlandreSee on map
Contributed capital
2 010 958,00 €
Latest accounts
31/12/2025
Average workforce
428,7 ETP
Joint committees (1)
  • 200
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 19 filings

Trend over 19 financial years

20252024202320222021
Income statement
Revenue60,1 M €67,9 M €71,7 M €68 M €60,6 M €
EBITDA2,7 M €-379,4 k €-1,3 M €3 M €3 M €
Operating result2 M €-1 M €-1,8 M €2,5 M €2,6 M €
Net result52,8 k €-1,9 M €-2,8 M €950,1 k €1,1 M €
Balance sheet
Equity1,7 M €1,6 M €853 k €3,6 M €3,6 M €
Total assets15,6 M €18,2 M €17,3 M €15,4 M €18,1 M €
Cash3,3 M €3,7 M €327,1 k €146,1 k €156,6 k €
Debts13,6 M €16,5 M €16,4 M €11,6 M €14,3 M €
Other
Workforce428,7 ETP468,6 ETP490,7 ETP466,5 ETP434,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 5 M€ and 10 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 51 ended

Active mandates

Cave Caenem

Managing director · since 01 juillet 2025 · until 18 avril 2031 · 0687.693.277

Represented by Alexander Van Caeneghem

Active
J.J. Smit Holding BV

Director · since 26 avril 2023 · until 20 avril 2029

Represented by Jacobus Johannes SMIT

Active

Ended mandates

Joost Pepijn DE BRUIN

Director · since 01 mars 2025 · until 18 avril 2031

Ended
TriFinance Holding BV

Director · since 28 mars 2024 · until 19 avril 2030

Represented by Caroline Fenna Theresa SCHOUTEN

Ended
XKG Advisory

Managing director · since 26 avril 2023 · until 20 avril 2029 · 0829.785.312

Represented by Xavier GABRIËLS

Ended
Jan Albert VAN AUTREVE

Director · since 01 septembre 2022 · until 21 avril 2028

Ended

Other companies at this address

Uitbreidingstraat 80 2600 Antwerpen
CompanyCBE no.
HuVePharma● Active
0875.283.062
0879.561.554

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/04/202603/04/202510/07/202415/05/202328/04/202219/05/2021
General meeting24/03/202627/03/202528/03/202426/04/202307/04/202216/04/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202524/03/202615/04/2026DutchPDF
Full model31/12/202427/03/202503/04/2025DutchPDF
Full model31/12/202328/03/202410/07/2024DutchPDF
Full model31/12/202226/04/202315/05/2023DutchPDF
Full model31/12/202107/04/202228/04/2022DutchPDF
Full model31/12/202016/04/202119/05/2021DutchPDF
Full model31/12/201917/04/202006/05/2020DutchPDF
Full model31/12/201810/05/201912/06/2019DutchPDF
Full model31/12/201720/04/201822/05/2018DutchPDF
Full model31/12/201621/04/201723/05/2017DutchPDF
Full model31/12/201515/04/201617/05/2016DutchPDF
Full model31/12/201417/04/201511/05/2015DutchPDF
Full model31/12/201318/04/201413/05/2014DutchPDF
Full model31/12/201219/04/201322/05/2013DutchPDF
Full model31/12/201120/04/201223/05/2012DutchPDF
Full model31/12/201015/04/201131/05/2011DutchPDF
Full model31/12/200916/04/201023/06/2010DutchPDF
Full model31/12/200819/06/200922/07/2009DutchPDF
Abridged model31/12/200720/06/200827/08/2008DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 5 M€ and 10 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 51 ended

Active mandates

Cave Caenem

Managing director · since 01 juillet 2025 · until 18 avril 2031 · 0687.693.277

Represented by Alexander Van Caeneghem

Active
J.J. Smit Holding BV

Director · since 26 avril 2023 · until 20 avril 2029

Represented by Jacobus Johannes SMIT

Active

Ended mandates

Joost Pepijn DE BRUIN

Director · since 01 mars 2025 · until 18 avril 2031

Ended
TriFinance Holding BV

Director · since 28 mars 2024 · until 19 avril 2030

Represented by Caroline Fenna Theresa SCHOUTEN

Ended
XKG Advisory

Managing director · since 26 avril 2023 · until 20 avril 2029 · 0829.785.312

Represented by Xavier GABRIËLS

Ended
Jan Albert VAN AUTREVE

Director · since 01 septembre 2022 · until 21 avril 2028

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Restructuring04/08/2026
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Restructuring04/08/2026
    KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates02/06/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other20/05/2026
    DIVERS
    PDF
  • Other20/05/2026
    DIVERSEN
    PDF
  • Mandates30/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/08/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates18/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202552,8 k €↑
  2. 2024
    Annual accounts 2024-1,9 M €↑
  3. 2023
    Annual accounts 2023-2,8 M €↓
  4. 2022
    Annual accounts 2022950,1 k €↓
  5. 2021
    Annual accounts 20211,1 M €↓
  6. 2020
    Annual accounts 20201,7 M €↑
  7. 2019
    Annual accounts 201918,5 k €↓
  8. 2018
    Annual accounts 2018489,2 k €↑
  9. 2017
    Annual accounts 2017-78,4 k €↓
  10. 2016
    Annual accounts 2016176,6 k €↓
  11. 2015
    Annual accounts 2015339,5 k €↓
  12. 2014
    Annual accounts 2014411,2 k €↑
  13. 2013
    Annual accounts 201378,3 k €↓
  14. 2012
    Annual accounts 2012573,8 k €↑
  15. 2011
    Annual accounts 2011326,3 k €↓
  16. 2010
    Annual accounts 2010765,3 k €↓
  17. 2009
    Annual accounts 20091,4 M €↑
  18. 2008
    Annual accounts 2008172,1 k €↑
  19. 2007
    Annual accounts 2007-128 k €
  20. 27/07/2006
    IncorporationPublic limited company